Assis Alessandra Faccin - 19 Nov 2025 Form 4 Insider Report for ASHLAND INC. (ASH)

Role
SVP and GM, Life Sciences
Signature
/s/ Serena S. Kenost, Attorney-in-Fact for Assis Alessandra Faccin
Issuer symbol
ASH
Transactions as of
19 Nov 2025
Net transactions value
$0
Form type
4
Filing time
21 Nov 2025, 16:30:22 UTC
Previous filing
17 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Assis Alessandra Faccin SVP and GM, Life Sciences 8145 BLAZER DRIVE, WILMINGTON /s/ Serena S. Kenost, Attorney-in-Fact for Assis Alessandra Faccin 21 Nov 2025 0001931500

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASH Restricted Stock Units Award $0 +6,136 $0.000000 6,136 19 Nov 2025 Common Stock 6,136 Direct F1, F2
transaction ASH Stock Appreciation Rights Award $0 +13,807 $0.000000 13,807 19 Nov 2025 Common Stock 13,807 $50.58 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (RSU) represents a right to receive one (1) share of ASH Common Stock.
F2 Grant of Restricted Stock Units on November 19, 2025, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant vest in three equal installments beginning one year from the date of grant, provided that the Reporting Person remains in continuous employment with the issuer.
F3 Stock Appreciation Rights (SARs) granted under the Ashland Inc. 2021 Omnibus Incentive Compensation Plan.
F4 SARs become exercisable ratably over three years beginning on the first anniversary from the date of grant.